Thierer Mark 4
4 · P3 Health Partners Inc. · Filed Mar 28, 2022
Insider Transaction Report
Form 4
Thierer Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-24+171,069→ 171,069 totalExercise: $7.95Exp: 2032-03-24→ Class A Common Stock (171,069 underlying) - Award
Stock Option (Right to Buy)
2022-03-24+200,000→ 200,000 totalExercise: $7.95Exp: 2032-03-24→ Class A Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable with respect to 50% of the shares on each of March 24, 2023 and March 24, 2024.
- [F2]The option vests and becomes exercisable with respect to 1/3 of the shares on each of March 24, 2023; March 24, 2024 and March 24, 2025.